Table 2 Correlation of clinico-pathologic variables and Ki-67 with NLR
Cases (n = 73) | NLR | Ch2-value | p-value | |
|---|---|---|---|---|
Low (n = 26) | High (n = 47) | |||
SBR grade | ||||
1 (n = 8) | 5 (62.5%) | 3 (37.5%) | 4.878 | > 0.05 |
2 (n = 56) | 20 (35.7%) | 36 (64.3%) | ||
3 (n = 9) | 1 (11.1%) | 8 (88.9%) | ||
Molecular subtype | ||||
Luminal A (n = 15) | 8 (53.3%) | 7 (46.7%) | 4.856 | > 0.05 |
Luminal B (n = 14) | 6 (42.9%) | 8 (57.1%) | ||
Triple negative (n = 28) | 6 (21.4%) | 22 (78.6%) | ||
Her2 enriched (n = 16) | 6 (37.5%) | 10 (62.5%) | ||
TNM stage | ||||
I (n = 0) | 0 | 0 | 36.948 | < 0.001 |
II (n = 43) | 25 (58.1%) | 18 (41.9%) | ||
III (n = 30) | 1 (3.3%) | 29 (96.7%) | ||
Ki-67 expression | ||||
Low (n = 11) | 11 (100%) | 0 | 43.107 | < 0.001 |
Intermediate (n = 21) | 13 (61.9%) | 08 (38.1%) | ||
High (n = 41) | 02 (4.9%) | 39 (95.1%) | ||